<DOC>
	<DOCNO>NCT02615288</DOCNO>
	<brief_summary>This randomize , double-blind placebo-controlled trial high dose vitamin D3 10,000 International Units ( IU ) daily compare low dose 1000 IU daily patient Crohn 's disease remission .</brief_summary>
	<brief_title>High Dose Vitamin D3 Crohn 's Disease</brief_title>
	<detailed_description>In patient Crohn 's disease remission , investigator hypothesize high dos vitamin D would effectively improve 25-hydroxy ( OH ) -vitamin D level would tolerate well without side effect hypercalcemia . The investigator also want explore whether high dos could reduce clinical relapse rate patient Crohn 's disease remission , high dos vitamin D3 could improve depression anxiety symptom . In order determine benefit high-dose vitamin D3 , investigator design pilot randomize double-blind control trial comparing dose oral vitamin D3 10,000 IU daily 1000 IU daily .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>prior diagnosis Crohn 's disease clinical remission least 28 day HarveyBradshaw index less equal 4 All maintenance therapy Crohn 's disease require stable dose least 3 month randomization , systemic steroid therapy within 4 week . Vitamin D supplement discontinue least 6 week randomization . Women child bear potential consider pregnancy study period , currently pregnant , unwilling use contraception avoid pregnancy Participants renal insufficiency ( serum creatinine great 150 umol/L ) , sarcoidosis , hyperparathyroidism , malignancy , disorder may lead hypercalcemia Patients shortgut syndrome serum albumin le 32 g/L Concomitant therapy thiazide diuretic , barbiturate , digitalis , supplemental product contain vitamin D</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Vitamin D</keyword>
</DOC>